Bill, I feel the opposite. I’m even more convinced that they are going about things in the right way. I think that Swami has well and truly made his mark.
With vascular treatments, it seems that the podiatrists couldn’t be trusted to prepare the wound bed properly (my interpolation).
By bringing into inpatient settings that can be controlled for better. I’d much prefer having a design that eliminates a possible spoiler of variable wound prep so that the benefits of the treatment over control are clear.
Ann: 1H FY24 Results Presentation, page-18
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.30 |
Change
0.000(0.00%) |
Mkt cap ! $1.590B | |||
| Open | High | Low | Value | Volume |
| $2.34 | $2.35 | $2.27 | $1.711M | 744.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 14000 | $2.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.30 | 13896 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |